Disposition of 2743 shares by Michael Raab of Ardelyx at 4.9 subject to Rule 16b-3

ARDX Stock  USD 5.16  0.11  2.18%   
Slightly above 53% of Ardelyx's investor base is interested to short. The analysis of the overall investor sentiment regarding Ardelyx suggests that many traders are impartial. Ardelyx's investing sentiment can be driven by a variety of factors including economic data, Ardelyx's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Ardelyx Director, Officer: President & Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at seekingalpha.com
seekingalpha News
  
Disposition of 2743 common stock at 4.9 of Ardelyx by Michael Raab on 11th of November 2024. This event was filed by Ardelyx with SEC on 2024-11-11. Statement of changes in beneficial ownership - SEC Form 4

Ardelyx Current Investor Sentiment

Panic Vs Confidence

47

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ardelyx's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ardelyx.

Ardelyx Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Ardelyx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ardelyx Historical Investor Sentiment

Investor biases related to Ardelyx's public news can be used to forecast risks associated with an investment in Ardelyx. The trend in average sentiment can be used to explain how an investor holding Ardelyx can time the market purely based on public headlines and social activities around Ardelyx. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ardelyx's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ardelyx and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ardelyx news discussions. The higher the estimate score, the more favorable the investor's outlook on Ardelyx.

Ardelyx Maximum Pain Price Across April 17th 2025 Option Contracts

Ardelyx's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Ardelyx close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Ardelyx's options.

Ardelyx Fundamental Analysis

We analyze Ardelyx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ardelyx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ardelyx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Ardelyx is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Ardelyx Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ardelyx stock to make a market-neutral strategy. Peer analysis of Ardelyx could also be used in its relative valuation, which is a method of valuing Ardelyx by comparing valuation metrics with similar companies.

Peers

Ardelyx Related Equities

HEPAHepion Pharmaceuticals   35.93   
0%
100.0%
PDSBPDS Biotechnology   12.75   
0%
35.0%
LXRXLexicon Pharmaceuticals   6.67   
0%
18.0%
TERNTerns Pharmaceuticals   4.94   
0%
13.0%
MCRBSeres Therapeutics   2.90   
0%
8.0%
BLRXBioLineRx   1.36   
0%
3.0%
ZURAZura Bio   1.13   
0%
3.0%
VSTMVerastem   0.18   
1.0%
0%
MREOMereo BioPharma   2.34   
6.0%
0%
HOOKHookipa Pharma   2.45   
6.0%
0%
IBRXImmunitybio   3.11   
8.0%
0%
INZYInozyme Pharma   3.70   
10.0%
0%

Additional Tools for Ardelyx Stock Analysis

When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.